Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
December 21, 2025
Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response
Daniel Navarro-Garcia, Francesco Grussu, Christina Zatse, et al.
Radiology. Artificial Intelligence
|
April 24, 2024
Erratum for: Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer
Olivia Prior, Carlos Macarro, Víctor Navarro, et al.
Radiology. Artificial Intelligence
|
January 31, 2024
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer
Olivia Prior, Carlos Macarro, Víctor Navarro, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Neuro-Oncology
|
May 31, 2022
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
Macarena I de la Fuente, Howard Colman, Mark Rosenthal, et al.
JTO Clinical and Research Reports
|
October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Ravit Geva, Maria Vieito, Jorge Ramon, et al.
Nature Communications
|
March 14, 2023
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Victor Moreno, Maria Vieito, Juan Manuel Sepulveda, et al.
Clinical and Translational Science
|
June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
Maria Vieito, Victor Moreno, Anna Spreafico, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
December 21, 2025
Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response
Daniel Navarro-Garcia, Francesco Grussu, Christina Zatse, et al.
Radiology. Artificial Intelligence
|
April 24, 2024
Erratum for: Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer
Olivia Prior, Carlos Macarro, Víctor Navarro, et al.
Radiology. Artificial Intelligence
|
January 31, 2024
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer
Olivia Prior, Carlos Macarro, Víctor Navarro, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Neuro-Oncology
|
May 31, 2022
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
Macarena I de la Fuente, Howard Colman, Mark Rosenthal, et al.
JTO Clinical and Research Reports
|
October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Ravit Geva, Maria Vieito, Jorge Ramon, et al.
Nature Communications
|
March 14, 2023
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Victor Moreno, Maria Vieito, Juan Manuel Sepulveda, et al.
Clinical and Translational Science
|
June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study
Joaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
Maria Vieito, Victor Moreno, Anna Spreafico, et al.
Page
of 4